Get a call back from our health advisor

in Hyderabad
Understanding BCR-ABL and the Quantitative RT-PCR Test
Introduction to BCR-ABL (Philadelphia Chromosome)
The BCR-ABL fusion gene, commonly known as the Philadelphia chromosome, is a genetic mutation associated with certain types of leukaemia. This chromosomal abnormality arises from a translocation between chromosomes 9 and 22. During this translocation, parts of these chromosomes break off and switch places, resulting in a new, abnormal gene on chromosome 22, termed BCR-ABL. This fusion gene produces a tyrosine kinase protein that drives the uncontrolled proliferation of white blood cells, characteristic of leukaemia.
The presence of the Philadelphia chromosome is a hallmark of Chronic Myeloid Leukaemia (CML), a type of cancer that affects the blood and bone marrow. It can also be found in some cases of Acute Lymphoblastic Leukaemia (ALL) and, less commonly, Acute Myeloid Leukaemia (AML). The mutation leads to the overproduction of white blood cells that do not mature properly, disrupting normal blood cell production and function.
Symptoms and Causes of BCR-ABL (Philadelphia Chromosome)
Symptoms:
- Fatigue: Individuals may experience persistent tiredness due to decreased red blood cell production.
- Fever: Elevated body temperature often results from infections or the disease itself.
- Easy Bruising or Bleeding: Increased tendency to bruise or bleed is common due to low platelet counts.
- Weight Loss: Unexplained weight loss can occur without changes in diet or exercise.
- Bone Pain: Discomfort or pain in bones, particularly in the sternum or long bones, may be experienced.
- Enlarged Spleen or Liver: Swelling of these organs can lead to feelings of fullness or discomfort.
Causes:
- Genetic Mutation: The BCR-ABL fusion gene is caused by a specific chromosomal translocation between chromosomes 9 and 22. This genetic mutation is usually acquired during the formation of blood cells rather than inherited.
- Exposure to Radiation: High levels of radiation, such as those used in cancer treatment, can increase the risk of developing leukaemia.
- Chemical Exposure: Prolonged exposure to certain chemicals, especially those used in chemotherapy, may also contribute to the development of leukaemia.
Diagnostic Tests for BCR-ABL (Philadelphia Chromosome)
Diagnosing the BCR-ABL gene involves several tests:
- Bone Marrow Biopsy: This procedure involves taking a sample of bone marrow from the hip bone to look for abnormal cells and genetic mutations. It is a primary diagnostic tool for leukaemia.
- Blood Tests: Complete blood counts (CBC) help detect abnormal levels of white blood cells, red blood cells, and platelets, which can indicate leukaemia.
- Cytogenetic Analysis: This test examines the chromosomes in cells to identify the Philadelphia chromosome. It is crucial for confirming the presence of the BCR-ABL gene.
- Fluorescence In Situ Hybridisation (FISH): Utilises fluorescent probes to detect the BCR-ABL gene fusion in cells. This method is used to visually confirm the presence of the genetic abnormality.
The OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test
What is the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test?
The OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR (Reverse Transcriptase Polymerase Chain Reaction) test is a sophisticated molecular diagnostic tool designed to detect and measure the BCR-ABL fusion gene. This test quantifies the amount of BCR-ABL mRNA (messenger RNA) in blood or bone marrow samples, providing critical insights into the level of leukaemia activity and the response to treatment.
Unlike qualitative tests that only confirm the presence of the BCR-ABL gene, the quantitative RT-PCR test measures the amount of abnormal mRNA. This quantitative data helps healthcare providers assess how well the disease is being managed and make informed decisions about treatment adjustments.
Who Should Get the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test Done?
The OS0179-BCR-ABL Quantitative RT-PCR test is recommended for:
- Patients Diagnosed with CML: This test is essential for monitoring the disease’s progression and evaluating how well the current treatment regimen is working.
- Individuals with ALL or AML: For patients suspected of having the Philadelphia chromosome, this test helps confirm the diagnosis and guide treatment decisions.
- Treatment Monitoring: Patients undergoing treatment for leukaemia need regular testing to track changes in disease activity and adjust treatment plans accordingly.
- Assessment of Minimal Residual Disease (MRD): The test is used to detect small amounts of leukaemia that may not be visible with other diagnostic methods but can impact prognosis and treatment strategies.
What Does the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test Measure?
The OS0179-BCR-ABL Quantitative RT-PCR test measures:
- BCR-ABL mRNA Levels: It quantifies the amount of abnormal mRNA produced by the BCR-ABL gene. Higher levels of this mRNA indicate greater disease activity.
- Disease Monitoring: By comparing current results with baseline levels, the test helps track the effectiveness of treatment and the progression of the disease.
- Treatment Efficacy: Helps in assessing how well the current therapy is working and guides adjustments to the treatment plan if necessary.
How to Prepare for the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR Test?
Preparation for the OS0179-BCR-ABL Quantitative RT-PCR test typically involves:
- Sample Collection: The test requires a blood sample or, in some cases, a bone marrow sample. Your healthcare provider will give instructions on how to provide these samples.
- No Special Preparation: Generally, there are no specific dietary or fasting requirements before the test. However, you should follow any specific instructions given by your healthcare provider.
- Informing About Medications: Inform your healthcare provider about any medications you are taking, as some treatments may affect test results or interpretation.
In summary, the OS0179-BCR-ABL (Philadelphia) Quantitative RT-PCR test is a vital tool in the diagnosis and management of leukaemia associated with the Philadelphia chromosome. By quantifying the BCR-ABL gene expression, this test provides crucial information for monitoring disease progression and treatment efficacy, ultimately contributing to better patient outcomes and personalised treatment strategies.
BCR-ABL (PHILADELPHIA) QUANTITATIVE RT - PCR (8)
Top Tests
Glucose-6-Phosphate Dehydrogenase (G6PD) Test
/
C-Peptide Test
/
Urine Sugar Test
/
Widal (Widal Agglutination) Test
/
Complete Blood Count (CBC) Test
/
HIAA Quantitative Test
/
24 Hour Urine Copper Test
/
24 Hour Urine Catecholamines Test
/
Acetylcholine Receptor (ACHR) Antibody Test
/
Complete Urine Examination (CUE) Test
/
Alanine Aminotransferase (ALT) Test
/
Albumin Test
/
Alcohol Blood Test
/
Creatinine Test
/
Aldolase Test
Aldosterone Test
/
Alkaline Phosphatase (ALP) Test
/
Alpha Fetoprotein (AFP) Test
/
17 Hydroxy Progesterone (OHP) Test
/
Blood Ketones (Acetone) Test
/
Double Marker (First Trimester Screening) Test
/
Alpha-1 Antitrypsin (A1AT) Test
/
Acid Fast Bacilli (AFB) Culture Test
/
Electrolytes Panel Test
/
Aluminium Test
/
Health Check Packages
Diabetes
/
Cardiovascular Diseases
/
Hypertension
/
Gut Health
/
Bone Health
/
Alcohol
/
Cancer
/
Depression
/
Nutrition Disorder
/
Obesity
/
Respiratory Disorders
/
Sexual Wellness
/
Sleep Disorder
/
For men: Under 30 years
/
For men: Age 30-45
/
For men: Age 45-60
/
For men: Above 60 years
/
For women: Under 30 years
/
For women: Age 30-45
/
For women: Age 45-60
/
For women: Above 60 years
/
Diagnostic Centre
Diagnostic Centre in Delhi
/
Diagnostic Centre in Hyderabad
/
Diagnostic Centre in Mumbai
/
Diagnostic Centre in Chennai
/
Diagnostic Centre in Bangalore
/
Diagnostic Centre in Pune
/
Diagnostic Centre in Kolkata
/
Diagnostic Centre in Jaipur
/
Diagnostic Centre in Ahmedabad
/
Diagnostic Centre in Gurgaon
/
Diagnostic Centre in Noida
/
Diagnostic Centre in Lucknow
/
Diagnostic Centre in Madurai
/
Diagnostic Centre in Guwahati
/
Diagnostic Centre in Amritsar
/
Partner with us
Partnering with us offers entrepreneurs valuable mentoring, marketing guidance, and administrative support, paving the way for success.
For bulk test bookings, Reach out to us at:
customer.care@apollodiagnostics.in
QUICK LINKS
ABOUT US
Move To Top
Copyright © 2024 Apollo Diagnostics (Apollo Health and Lifestyle Limited), All Rights Reserved